SCHEMBL4167685

SCHEMBL4167685

CC(C)c1cc2cc(Cl)cc(Cc3ccc(C(=O)Nc4ccc(CN5CCCC5)cc4)o3)c2o1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 6/20 0.55
L3MBTL1 Q9Y468 2/20 0.48
SMN1; SMN2 Q16637 6/20 0.46
ALDH1A1 P00352 4/20 0.46
KMT2A Q03164 4/20 0.46
HPGD P15428 3/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 2/20 0.46
HTT P42858 2/20 0.46
MEN1 O00255 2/20 0.46
MAPK1 P28482 2/20 0.46
PRKD3 O94806 1/20 0.46
PRKD1 Q15139 1/20 0.46
PRKD2 Q9BZL6 1/20 0.46
LMNA P02545 4/20 0.44
POLB P06746 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4157725 0.94 PTGER1 (0.54) PTGER1L3MBTL1SMN1; SMN2ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL4162562 0.93 PTGER1 (0.53) PTGER1L3MBTL1SMN1; SMN2ALDH1A1KMT2A
SCHEMBL4167783 0.92 PTGER1 (0.52) PTGER1L3MBTL1SMN1; SMN2ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL4168845 0.91 PTGER1 (0.51) PTGER1L3MBTL1SMN1; SMN2ALDH1A1KMT2A
SCHEMBL4162628 0.87 PTGER1 (0.55) PTGER1SMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL4160757 0.85 PTGER1 (0.53) PTGER1SMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL4157559 0.84 PTGER1 (0.56) PTGER1SMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL4157432 0.84 PTGER1 (0.60) PTGER1SMN1; SMN2KDM4ENPC1RAB9A
Hydrochloric Acid SCHEMBL4161533 0.83 PTGER1 (0.55) PTGER1SMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL4164383 0.82 MEN1 (0.49) PTGER1SMN1; SMN2ALDH1A1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2009-04-16 US claimed
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2009-04-16 US disclosed
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2009-04-16 US disclosed
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2009-04-16 US disclosed
WO-2007113289-A1 BENZOFURAN COMPOUNDS AS EP1 RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists PTGER1, PTGER2, PTGER3 PTGER1 1/4885L3MBTL1 2124/4885SMN1; SMN2 2462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.